The Role of Vitamin D in Obese Children with Non-Alcoholic Fatty Liver Disease and Associated Metabolic Syndrome
Nutrients · 2023
DOI: 10.3390/nu15092113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Mioara Desdemona Stepan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infant Care-Pediatrics-Neonatology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania. Hauptthemen laut MEDLINE: Metabolic Syndrome, Non-alcoholic Fatty Liver Disease, Pediatric Obesity, Obesity, Morbid. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy of Craiova, University of Medicine and Pharmacy of Craiova, Romania.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Non-alcoholic fatty liver disease (NAFLD) represents a complex chronic condition, which in the absence of screening–monitoring markers and effective standardized treatment is one of the most important issues in pediatric pathology. In this study, we analyzed the role of vitamin D supplementation in obese children with/without NAFLD and the impact on the components of the associated metabolic syndrome (MS). The study included 22 children with simple obesity (SO) and 50 with NAFLD, aged between 6 and 14 years, who received regimen-based therapy or vitamin D supplementation in case of deficiency. Anthropometric and paraclinical data associated with MS were statistically compared before and after treatment. It was observed that there was a statistical association of NAFLD with MS components, which were present both in SO and in the 6–9 years group. Vitamin D deficiency was associated with the presence of obesity, NAFLD and MS components, and correction of the deficiency induced a tendency to normalize the associated parameters. In the case of a treatment strictly based on the regimen, we found decreases in vitamin D values and additional alteration of some parameters. Supplementation with vitamin D potentiates the effects of the specific regimen, and the effects seem to be dependent on the MS components.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infant Care-Pediatrics-Neonatology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Laboratory of Human Genomics, University of Medicine and Pharmacy of Craiova, 200638 Craiova, Romania.
- Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Research Center of Gastroenterology and Hepatology, University of Medicine and Pharmacy Craiova, 200349 Craiova, Romania.
ORCID-Profile: Mioara Desdemona Stepan, Ștefănița Bianca Vintilescu
Förderung
- University of Medicine and Pharmacy of Craiova
- University of Medicine and Pharmacy of Craiova, Romania
Zitieren
APA
Stepan, M. D., Vintilescu, Ș. B., Streață, I., Podeanu, M. A., & Florescu, D. N. (2023). The Role of Vitamin D in Obese Children with Non-Alcoholic Fatty Liver Disease and Associated Metabolic Syndrome. Nutrients. https://doi.org/10.3390/nu15092113
Vancouver
Stepan MD, Vintilescu ȘB, Streață I, Podeanu MA, Florescu DN. The Role of Vitamin D in Obese Children with Non-Alcoholic Fatty Liver Disease and Associated Metabolic Syndrome. Nutrients. 2023. doi:10.3390/nu15092113
BibTeX
@article{Stepan2023,
author = {Stepan, Mioara Desdemona and Vintilescu, Ștefănița Bianca and Streață, Ioana and Podeanu, Mihaela Andreea and Florescu, Dan Nicolae},
title = {The Role of Vitamin D in Obese Children with Non-Alcoholic Fatty Liver Disease and Associated Metabolic Syndrome},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15092113}
}
EUVIMED